메뉴 건너뛰기
Neurological Sciences
Volumn 34, Issue 5, 2013, Pages 655-661
Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome
Author keywords

Acute inflammatory demyelinating polyneuropathy; Acute motor axonal neuropathy; Guillain Barr syndrome; Phosphorylated neurofilament heavy protein; S100B; Tau
Indexed keywords

IMMUNOGLOBULIN G; NEUROFILAMENT HEAVY PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN S100B; TAU PROTEIN; UNCLASSIFIED DRUG;
EID: 84878014004     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-1092-z     Document Type: Article
Times cited : (19)
References (18)
  • 1
    • 0032558184 scopus 로고    scopus 로고
    • Guillain-Barré syndrome
    • 9746040 10.1016/S0140-6736(97)12308-X 1:STN:280:DyaK1cvhslWhsA%3D%3D
    • Hahn AF (1998) Guillain-Barré syndrome. Lancet 352:635-641
    • (1998) Lancet , vol.352 , pp. 635-641
    • Hahn, A.F.1
  • 2
    • 67349199109 scopus 로고    scopus 로고
    • Guillain-Barré syndrome: An update
    • 19356935 10.1016/j.jocn.2008.08.033
    • Vucic S, Kiernan MC, Cornblath DR (2009) Guillain-Barré syndrome: an update. J Clin Neurosci 16:733-741
    • (2009) J Clin Neurosci , vol.16 , pp. 733-741
    • Vucic, S.1    Kiernan, M.C.2    Cornblath, D.R.3
  • 3
    • 62149129699 scopus 로고    scopus 로고
    • Cerebrospinal fluid biomarkers in Guillain-Barré syndrome - Where do we stand?
    • 19267167 10.1007/s00415-009-0097-x 1:CAS:528:DC%2BD1MXisl2qsr8%3D
    • Brettschneider J, Petzold A, Süssmuth S, Tumani H (2009) Cerebrospinal fluid biomarkers in Guillain-Barré syndrome - where do we stand? J Neurol 256:3-12
    • (2009) J Neurol , vol.256 , pp. 3-12
    • Brettschneider, J.1    Petzold, A.2    Süssmuth, S.3    Tumani, H.4
  • 4
    • 1842425019 scopus 로고    scopus 로고
    • Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy
    • 15052622 10.1002/mus.20022
    • Van Den Bergh PY, Piéret F (2004) Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 29:565-574
    • (2004) Muscle Nerve , vol.29 , pp. 565-574
    • Van Den Bergh, P.Y.1    Piéret, F.2
  • 5
    • 0018119702 scopus 로고
    • Controlled trial prednisolone in acute polyneuropathy
    • 80682 10.1016/S0140-6736(78)92644-2 1:STN:280:DyaE1M%2FgvFKjtg%3D%3D
    • Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2:750-753
    • (1978) Lancet , vol.2 , pp. 750-753
    • Hughes, R.A.1    Newsom-Davis, J.M.2    Perkin, G.D.3    Pierce, J.M.4
  • 6
    • 0019450538 scopus 로고
    • Pathology of the Guillain-Barré syndrome
    • 7224616 10.1002/ana.410090704
    • Prineas JW (1981) Pathology of the Guillain-Barré syndrome. Ann Neurol 9(suppl):6-19
    • (1981) Ann Neurol , vol.9 , Issue.SUPPL. , pp. 6-19
    • Prineas, J.W.1
  • 7
    • 27644558148 scopus 로고    scopus 로고
    • Guillain-Barré syndrome
    • 16271648 10.1016/S0140-6736(05)67665-9 1:CAS:528:DC%2BD2MXhtFOhu7%2FP
    • Hughes RA, Cornblath DR (2005) Guillain-Barré syndrome. Lancet 366:1653-1666
    • (2005) Lancet , vol.366 , pp. 1653-1666
    • Hughes, R.A.1    Cornblath, D.R.2
  • 8
    • 0029859323 scopus 로고    scopus 로고
    • Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
    • 8871584 10.1002/ana.410400414 1:STN:280:DyaK2s%2FisFeqtg%3D%3D
    • Hafer-Macko C, Hsieh ST, Li CY et al (1996) Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40:635-644
    • (1996) Ann Neurol , vol.40 , pp. 635-644
    • Hafer-Macko, C.1    Hsieh, S.T.2    Li, C.Y.3
  • 9
    • 51449103646 scopus 로고    scopus 로고
    • Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
    • 18848313 10.1016/S1474-4422(08)70215-1
    • Van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 7:939-950
    • (2008) Lancet Neurol , vol.7 , pp. 939-950
    • Van Doorn, P.A.1    Ruts, L.2    Jacobs, B.C.3
  • 10
    • 0028207122 scopus 로고
    • Prognostic value of cerebrospinal fluid neuron specific enolase and S-100b protein in Guillain-Barré syndrome
    • 8178624 10.1111/j.1600-0404.1994.tb01628.x 1:STN:280:DyaK2c3jtl2htg%3D%3D
    • Mokuno K, Kiyosawa K, Sugimura K et al (1994) Prognostic value of cerebrospinal fluid neuron specific enolase and S-100b protein in Guillain-Barré syndrome. Acta Neurol Scand 89:27-30
    • (1994) Acta Neurol Scand , vol.89 , pp. 27-30
    • Mokuno, K.1    Kiyosawa, K.2    Sugimura, K.3
  • 11
    • 0035831280 scopus 로고    scopus 로고
    • Tau protein in cerebrospinal fluid (CSF): A blood-CSF barrier related evaluation in patients with various neurological diseases
    • 11207383 10.1016/S0304-3940(01)01556-7
    • Süssmuth SD, Reiber H, Tumani H (2001) Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases. Neurosci Lett 300:95-98
    • (2001) Neurosci Lett , vol.300 , pp. 95-98
    • Süssmuth, S.D.1    Reiber, H.2    Tumani, H.3
  • 12
    • 33750376704 scopus 로고    scopus 로고
    • CSF tau protein: A new prognostic marker for Guillain-Barré syndrome
    • 17060576 10.1212/01.wnl.0000240119.29939.c7 1:CAS:528:DC%2BD28XhtVKrt7jO
    • Jin K, Takeda A, Shiga Y et al (2006) CSF tau protein: a new prognostic marker for Guillain-Barré syndrome. Neurology 67:1470-1472
    • (2006) Neurology , vol.67 , pp. 1470-1472
    • Jin, K.1    Takeda, A.2    Shiga, Y.3
  • 13
    • 0142071146 scopus 로고    scopus 로고
    • A specific ELISA for measuring neurofilament heavy chain phosphoforms
    • 12957406 10.1016/S0022-1759(03)00189-3 1:CAS:528:DC%2BD3sXmvVOhtrs%3D
    • Petzold A, Keir G, Green AJ, Giovannoni G, Thompson EJ (2003) A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods 278:179-190
    • (2003) J Immunol Methods , vol.278 , pp. 179-190
    • Petzold, A.1    Keir, G.2    Green, A.J.3    Giovannoni, G.4    Thompson, E.J.5
  • 14
    • 79953315948 scopus 로고    scopus 로고
    • Levels of phosphorylated axonal neurofilament subunit H (pNFH) are increased in acute ischemic stroke
    • 21349546 10.1016/j.jns.2011.01.025 1:CAS:528:DC%2BC3MXktFKmt7c%3D
    • Singh P, Yan J, Hull R et al (2011) Levels of phosphorylated axonal neurofilament subunit H (pNFH) are increased in acute ischemic stroke. J Neurol Sci 304:117-121
    • (2011) J Neurol Sci , vol.304 , pp. 117-121
    • Singh, P.1    Yan, J.2    Hull, R.3
  • 15
    • 46149089887 scopus 로고    scopus 로고
    • Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome
    • 18343991 10.1007/s10571-007-9257-7 1:CAS:528:DC%2BD1cXnvVyisbw%3D
    • Yang YR, Liu SL, Qin ZY et al (2008) Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome. Cell Mol Neurobiol 28:737-744
    • (2008) Cell Mol Neurobiol , vol.28 , pp. 737-744
    • Yang, Y.R.1    Liu, S.L.2    Qin, Z.Y.3
  • 16
    • 0037046983 scopus 로고    scopus 로고
    • Quality of life complements traditional outcome measures in immune-mediated polyneuropathies
    • 12105312 10.1212/WNL.59.1.84 1:STN:280:DC%2BD38zmtVOltQ%3D%3D
    • Merkies IS, Schmitz P, Van Der Meche FG et al (2002) Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 59:84-91
    • (2002) Neurology , vol.59 , pp. 84-91
    • Merkies, I.S.1    Schmitz, P.2    Van Der Meche, F.G.3
  • 17
    • 33748993683 scopus 로고    scopus 로고
    • CSF neurofilament levels: A potential prognostic marker in Guillain-Barré syndrome
    • 17000982 10.1212/01.wnl.0000237334.69665.92 1:STN:280: DC%2BD28rnt1SgtQ%3D%3D
    • Petzold A, Hinds N, Murray NM et al (2006) CSF neurofilament levels: a potential prognostic marker in Guillain-Barré syndrome. Neurology 67:1071-1073
    • (2006) Neurology , vol.67 , pp. 1071-1073
    • Petzold, A.1    Hinds, N.2    Murray, N.M.3
  • 18
    • 67650234232 scopus 로고    scopus 로고
    • CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome
    • 19533642 10.1002/mus.21239 1:CAS:528:DC%2BD1MXptVaqtro%3D
    • Petzold A, Brettschneider J, Jin K et al (2009) CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome. Muscle Nerve 40:42-49
    • (2009) Muscle Nerve , vol.40 , pp. 42-49
    • Petzold, A.1    Brettschneider, J.2    Jin, K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.